Cyfuse Biomedical K.K. (4892.T)

JPY 463.0

(2.89%)

Annual Cash Flows

(In JPY)
Breakdown 2023 2022 2021 2020
Operating Cash Flow -562.29 Million -403.59 Million 161.53 Million -294 Million
Net Income -586.18 Million -471.95 Million 144.91 Million -327.49 Million
Depreciation & Amortization 38.12 Million 54.28 Million 18.49 Million 32.89 Million
Deferred income taxes - - - -
Stock-based compensation - - - -
Change in working capital -5.37 Million -39.2 Million -10.55 Million -19.54 Million
Other non-cash items -124.91 Million 55.9 Million -69.61 Million -34.46 Million
Investing Cash Flow -19.47 Million -430.67 Million -50.58 Million -264 Thousand
Investments in PPE -19.47 Million -228.27 Million - -264 Thousand
Acquisitions - - - -
Investment purchases - -200 Million -100 Million -
Sales/Maturities of investments - - 100 Million -
Other Investing Activities - -2.39 Million -50.58 Million -
Financing Cash Flow 18.23 Million 2.65 Billion 229.2 Million 488.9 Million
Debt repayment -4.64 Million -336.94 Million -44.84 Million -446.35 Million
Dividends payments - - - -
Common Stock Repurchased - - - -
Common Stock Issuance 22.88 Million 2.32 Billion 207.75 Million 100 Million
Other Financing Activities 95 Million 1.35 Million -7.3 Million -42.31 Million
Accounts receivables -3 Million 44 Million -21.9 Million -8.77 Million
Accounts payables -1.91 Million -5.07 Million 7.73 Million -56.41 Million
Inventory -5.64 Million 21.36 Million -38.52 Million 20.85 Million
Other working capital -112 Million -62 Million 44.82 Million 26.19 Million
Cash at beginning of period 3.43 Billion 1.61 Billion 1.27 Billion 1.07 Billion
Cash at end of period 2.87 Billion 3.43 Billion 1.61 Billion 1.27 Billion
Capital Expenditure -19.47 Million -228.27 Million - -264 Thousand
Effect of forex changes on cash - - - -
Net cash flow / Change in cash -563.53 Million 1.82 Billion 340.16 Million 194.64 Million
Free Cash Flow -581.77 Million -631.87 Million 161.53 Million -294.26 Million

Cash Flow Charts